SNU-C1 Cells

Unit

5 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Intestine cancer cell lines

Organism

Human

Donor History

Colon adenocarcinoma

Growth Properties

Suspension

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/SNU-C1-Cells/305875

SKU: 305875 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The SNU-C1 cell line is a human colorectal carcinoma model established from the ascitic fluid of a Korean adult patient. It originates from a moderately differentiated adenocarcinoma of the colon and represents one of a group of SNU-series cell lines derived from colorectal cancer patients. SNU-C1 has been used in numerous studies focused on gastrointestinal cancer biology and pharmacogenomics due to its molecular features and relatively stable growth characteristics under in vitro conditions.

Genomically, SNU-C1 is characterized by microsatellite instability (MSI), a phenotype frequently observed in a subset of colorectal cancers due to defects in the DNA mismatch repair (MMR) system. This MSI status has significant implications for drug sensitivity and genomic instability. Despite harboring multiple genetic alterations common to colorectal carcinoma, including mutations in key pathways such as WNT and p53, SNU-C1 shows distinct proteomic and transcriptomic profiles that make it suitable for molecular subtype classification and high-throughput drug response profiling. It has been included in large-scale datasets such as the Cancer Cell Line Encyclopedia (CCLE), where proteomic quantification confirms expression patterns consistent with epithelial origin and MSI phenotype. These attributes make SNU-C1 a valuable resource for studying therapeutic responses in MSI-high colorectal cancers and for understanding the molecular diversity within colorectal tumors.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.